The Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) announced that Eric Cantor has been named the organization's next president and chief executive officer, bringing decades of experience at the intersection of business and public policy to lead the organization at a pivotal mome…
The Medical College of Wisconsin (MCW), one of the nation's top-performing academic medical centers and third-largest private medical school in the United States, formally inaugurated Shekar N. Kurpad, MD, PhD, as its seventh President and Chief Executive Officer. Dr. Kurpad set forth an ambitious vision that seeks t…
CordenPharma, a leading global pharmaceutical CDMO, announced the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer, effective 1 October 2026, as the company enters its next phase of growth. Dr. Herbeaux will succeed Dr. Michael Quirmbach, who has served as CordenPharma's Chief Executive Officer since 2…
GBI Biomanufacturing, Inc., a contract development and manufacturing organization (CDMO) specializing in complex biologics announced the appointment of Jesse McCool, Ph.D., as Chief Executive Officer. Dr. McCool joined GBI in late 2025 and most recently served as President and Chief Operating Officer. GBI, Dr. McCool…
Lonza, the world’s leading contract development and manufacturing organization (CDMO), today announced the appointment of Samanta Cimitan as Chief Commercial Officer (CCO), Senior Vice President and Member of the Extended Executive Committee. Samanta will join Lonza by 1 January 2027. Wolfgang Wienand, Chief Executi…
Rose BioSolutions, a leading provider of advanced manufacturing capabilities and cellular materials across the cell and gene therapy space, announced the appointment of David Enloe as Chief Executive Officer. "As one of the pioneers who helped build the cell and gene therapy industry from its earliest days, David has…
The Medical College of Wisconsin (MCW) is proud to announce that, effective, Brett Kissela, MD, GME '96, MS, has been appointed Executive Vice President for Health Affairs and the Julia A. Uihlein Dean of the School of Medicine. A nationally recognized neurologist, stroke epidemiologist, and clinician-scientist, Dr. K…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, announced the appointment of Mr. Youchen Chen, Chief Financial Officer, and Dr. Ian Y. Liu, Senior Vice President and Global Head of Legal, as Executive …
Aspen Medical Products (Aspen), the industry leader in spine solutions for pain and mobility management, announced an important enhancement to its executive leadership structure designed to support the company's continued growth and long-term strategic objectives. Effective immediately, Aspen has separated the combin…
Daiichi Sankyo has appointed Ken Keller to the newly created role of Chief Commercialization Officer, responsible for accelerating further growth of the company’s oncology and specialty medicine business through a new globally integrated Commercialization Unit, effective April 1, 2027. As part of the operational exce…
Page 1 of 15